Articles from Glancy Prongay & Murray

Glancy Prongay & Murray LLP (“GPM”) announces its investigation of American Oncology Network, Inc. (f/k/a Digital Transformation Opportunities Corp.) (AONC) Target Hospitality Corp. (Nasdaq: TH) (f/k/a Platinum Eagle Acquisition Corp) concerning the Company and its directors’ and officers’ possible violations of state laws.

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Five Below, Inc. (“Five Below” or the “Company”) (NASDAQFIVE) securities between March 20, 2024 to July 16, 2024, inclusive (the “Class Period”). Five Below investors have until September 30, 2024 to file a lead plaintiff motion.

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Equinix, Inc. (“Equinix” or the “Company”) (NASDAQEQIX) securities between May 3, 2019 and March 24, 2024, inclusive (the “Class Period”). Equinix investors have until July 1, 2024 to file a lead plaintiff motion.

Glancy Prongay & Murray LLP (“GPM”) announces its investigation of WillScot Mobile Mini Holdings Corp. (Nasdaq: WSC) (f/k/a Double Eagle Acquisition Corp.) concerning the Company and its directors’ and officers’ possible violations of state laws.

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Barclays PLC (“Barclays” or the “Company”) (NYSEBCS) American Depositary Receipts (“ADRs”) between February 18, 2021 to March 25, 2022, inclusive (the “Class Period”). Barclays investors have until November 22, 2022 to file a lead plaintiff motion.